The meeting focused on the latest international practices governing specialized pharmacy units, including regulatory policies, licensing requirements, and oversight mechanisms to ensure the safety and efficacy of preparations made within these units.
Dr. El-Ghamrawy affirmed the EDA's commitment to supporting
the pharmaceutical industry, emphasizing that compounding pharmacy is a key
area of focus due to its vital role in improving patient care and meeting
precise medical needs. He stressed that the EDA operates under a clear
legislative framework to guarantee safety and effectiveness.
He explained that strengthening partnerships with
specialized international entities, such as Global Fusion, will enhance the
efficiency of pharmaceutical services and preparation practices, ensuring
compliance with Egyptian law.
The Global Fusion delegation showcased the company's
international expertise and successful models in the field, allowing the EDA to
review leading global practices.
The EDA confirmed its continued efforts to foster international cooperation to enhance the efficiency of the pharmaceutical system, support the sustainable development of specialized pharmacy in Egypt, and ensure the application of the highest quality and regulatory standards for public health protection.